SITASON D 100/10 TABLET is used to manage type II diabetes mellitus which is inadequately controlled on metformin monotherapy. It is a combination of Dapagliflozin and Sitagliptin which belongs to the group of medicines called Antidiabetic agents. It effectively controls blood sugar levels where dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and Sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.
SITASON D 100/10 TABLET is not recommended for use in patients having severe kidney problems or those on dialysis. Before taking the medicine, inform your doctor if you have inflammation of the pancreas, gallstones, alcohol dependence, or very high levels of triglycerides in the blood or any heart, kidney or liver problems. It should be used in pregnant women only if considered clearly necessary. It should be used with caution in breastfeeding women. Safety and effectiveness of SITASON D 100/10 TABLET in children and adolescents (under 18 years of age) have not been established.
It is important to stay on the diet and exercise recommended by your doctor while taking SITASON D 100/10 TABLET as it can help the body use its blood sugar better. The most common side effects are headache, flatulence and constipation. Consult your doctor if any of the side effects worsen or persist for a longer period of time.
SITASON D 100/10 TABLET effectively controls blood sugar levels where Dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and Sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.
Stop taking SITASON D 100/10 TABLET and contact your physician immediately if you experience any of the following side effects:
If you are pregnant or think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
It is not known if this medicine passes into breast milk. You should not take this medicine if you are breast-feeding or plan to breast-feed.
Do not drive or operate any machines if you feel dizzy or sleepy after taking SITASON D 100/10 TABLET.
Avoid consumption of alcohol while taking SITASON D 100/10 TABLET as it may increase the chance of diabetic ketoacidosis.
SITASON D 100/10 TABLET can be used with caution in patients who had or have any kidney problems.
SITASON D 100/10 TABLET can be used with caution in patients with severe liver impairment.
Do not take SITASON D 100/10 TABLET if you are allergic to Dapagliflozin, Sitagliptin or any other ingredients of this medicine.
SITASON D 100/10 TABLET can be used with caution in patients who have heart failure.
Safety and effectiveness of SITASON D 100/10 TABLET in children and adolescents (under 18 years of age) have not been established.
No dose adjustment is required for elderly patients.
SITASON D 100/10 TABLET is not recommended for use if you have:
Before taking SITASON D 100/10 TABLET inform your doctor if you:
A. Drug-Drug interactions:
Before taking SITASON D 100/10 TABLET, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally takes too much of SITASON D 100/10 TABLET, consult your doctor or visit a nearby hospital immediately.
Drug | : | Dapagliflozin, Sitagliptin |
Pharmacological Category | : | Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor, Dipeptidyl Peptidase 4 (DPP-4) inhibitor |
Therapeutic Indication | : | Type II diabetes mellitus |
Dosage Forms | : | Tablet |
Disease Description:
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both. The symptoms of diabetes mellitus are related to high blood glucose levels. They include excessive urination, thirst and hunger, weight loss, increased susceptibility to infections, especially yeast or fungal infections.
A: SITASON D 100/10 TABLET is a combination of Dapagliflozin and Sitagliptin which belongs to the group of medicines called Antidiabetic agents. It is used to manage type II diabetes mellitus which is inadequately controlled on metformin monotherapy.
A: Yes, SITASON D 100/10 TABLET may cause weight loss in some individuals. To avoid weight loss, follow a healthy diet and regular physical activity as advised by your physician.
A: Taking SITASON D 100/10 TABLET along with insulin might increase the chance of hypoglycemia.
A: SITASON D 100/10 TABLET effectively controls blood sugar levels where dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and Sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.
A: SITASON D 100/10 TABLET can be used with caution in patients who had or have any kidney problems. Your doctor may monitor your kidney function test before and during management with this medicine to manage the risk of any unusual effects.
1. KD. Tripathi. Insulin, Oral Antidiabetic Drugs and Glucagon. Essentials of Medical Pharmacology. Eighth edition. 2019. Page – 297 & 301.
2. Serge A. Jabbour; Elise Hardy; Jennifer Sugg; Shamik Parikh. Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Journal of Diabetes care. American Diabetes Association. February 2014. [Accessed on 27th November 2023] click here
3. Annaswamy Raji, Zhi Jin Xu, Raymond L. H. Lam, Edward A.O’Neill, Keith D. Kaufman, Samuel S. Engel. Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency. SpringerLink. August 2020. [Accessed on 27th November 2023] click here
4. Torrent Pharmaceuticals Ltd. Sitaxa D/ Sitalix D/Glucreta S (Dapagliflozin + Sitagliptin). [Revised in July 2022] [Accessed on 27th November 2023] click here
5. Cipla Ltd. Exemed Pharmaceuticals. Darasach S (Dapagliflozin + Sitagliptin). Ciplamed. [Revised in September 2022] [Accessed on 27th November 2023] click here
Was this information helpful? Share it with your friends
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.